Home
Market Capitalization of Corona Remedies Ltd
From Blinkx's GPT
Key Highlights
- The Latest Trading Price of Corona Remedies Ltd is ₹ 1437 as of 15 Dec 15:30 .
Corona Remedies Ltd
NSE: CORONA
Share Price
Market Price of Corona Remedies Ltd
1M
1Y
3Y
5Y
SWOT Analysis Of Corona Remedies Ltd
BlinkX Score for Corona Remedies Ltd
Asset Value vs Market Value of Corona Remedies Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Corona Remedies Ltd
Historical P/E Ratio of Corona Remedies Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Corona Remedies Ltd
Historical Revenue of Corona Remedies Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Corona Remedies Ltd
Historical EBITDA of Corona Remedies Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Corona Remedies Ltd
Historical Net Profit of Corona Remedies Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Corona Remedies Ltd
Dividend Payout Over Time
About Corona Remedies Ltd
- Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
- Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
- A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
- The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.
Corona Remedies Ltd News Hub
Shares of Corona Remedies list in B group
The equity shares of Corona Remedies (Scrip Code: 544644) are listed effective 15 December 2025 and
Read more
15 Dec 25
Corona Remedies spurts on market debut
The stock was listed at Rs 1,452, exhibiting a premium of 36.72% to the issue price. So far, the sto
Read more
15 Dec 25
Corona Remedies
Corona Remedies is an India-focused branded pharmaceutical formulation company developing, manufactu
Read more
04 Dec 25
Corona Remedies IPO subscribed 62%
Corona Remedies received bids for 28,17,234 shares as against 45,71,882 shares on offer, according t
Read more
08 Dec 25
